Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AUDIOEYE INC Director's Dealing 2018

Dec 31, 2018

33790_dirs_2018-12-31_8b19cf7d-896c-49e7-bcc2-865e62233325.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AUDIOEYE INC (AEYE)
CIK: 0001362190
Period of Report: 2018-12-28

Reporting Person: Bettis Carr (Director, Exec Chrmn/Chrmn of the Board, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-12-28 Common Stock M 30000 $1.025 Acquired 80000 Direct
2018-12-31 Common Stock A 20000 Acquired 100000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-12-28 Stock Options (right to buy) $1.025 M 20000 Disposed 2018-12-31 Common Stock (20000) Direct
2018-12-28 Warrants (right to buy) $1.025 M 10000 Disposed 2018-12-31 Common Stock (10000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 508988 Indirect
Common Stock 18600 Indirect
Common Stock 54856 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options (right to buy) $11.25 2019-03-24 Common Stock (12000) 12000 Direct
Stock Options (right to buy) $0.95 2019-01-14 Common Stock (20000) 20000 Direct
Stock Options (right to buy) $0.95 2021-12-31 Common Stock (80000) 80000 Direct
Warrants (right to buy) $4 2020-06-02 Common Stock (80000) 80000 Direct
Warrants (right to buy) $0.95 2019-02-14 Common Stock (10000) 10000 Direct
Warrants (right to buy) $1.925 2019-02-28 Common Stock (20000) 20000 Direct
Warrants (right to buy) $4.475 2019-04-14 Common Stock (13920) 13920 Direct
Warrants (right to buy) $3.9 2019-07-15 Common Stock (15785) 15785 Direct
Warrants (right to buy) $6.25 2021-04-17 Common Stock (4000) 4000 Indirect
Warrants (right to buy) $6.25 2021-05-16 Common Stock (4480) 4480 Indirect
Warrants (right to buy) $6.25 2021-12-19 Common Stock (3200) 3200 Indirect
Warrants (right to buy) $15 2019-12-31 Common Stock (1875) 1875 Indirect
Series A Convertible Preferred Stock $ Common Stock (26801) 26801 Indirect

Footnotes

F1: The reported transaction constitutes a grant of restricted stock units, which were granted under the Issuer's Stock Incentive Plan, subject to vesting and settlement conditions.

F2: Dr. Bettis is deemed the sole manager of CSB IV US Holdings LLC. J. Carr & Stephanie V. Bettis Revocable Trust, Dated 1/1/03 (3) is deemed the beneficial owner of CSB IV US Holdings LLC.

F3: Dr. Bettis is deemed the beneficial owner of Carr Bettis IRA.

F4: Dr. Bettis is deemed the beneficial owner of J. Carr & Stephanie V. Bettis Revocable Trust, Dated 1/1/03.

F5: On December 28, 2018, AudioEye, Inc. issued 20,000 shares of common stock to Dr. Bettis upon the cash exercise of Stock Options at an exercise price of $1.025. The option was originally granted on October 26, 2015 with an extended expiration date to December 31, 2018.

F6: On December 28, 2018, AudioEye, Inc. issued 10,000 shares of common stock to Dr. Bettis upon the cash exercise of Warrants at an exercise price of $1.025. The option was originally granted on October 26, 2015 with an extended expiration date to December 31, 2018.

F7: The stock option vests as follows: 1/2 on the one-year anniversary of the date of grant; 1/48th on the monthly anniversary of the date of grant on each of the 24 months following the one-year anniversary of the date of grant.

F8: The stock option vests as follows: subject to performance schedule and determined at the end of each calendar year.

F9: The shares of Series A Convertible Preferred Stock of the Issuer ("Series A Preferred Stock") were immediately convertible upon issuance and do not expire.

F10: Each share of Series A Preferred Stock shall be convertible, at any time and from time to time into that number of shares of the Issuer's common stock determined by dividing $10 (the "Stated Value") plus any accrued dividends with respect to such share by the Conversion Price of $4.385, subject to adjustment as described in the Certificate of Designations for the Series A Preferred Stock (the "Series A COD").

F11: Holders of shares of Series A Preferred Stock are entitled to receive, when, as and if declared by the Board of Directors of the Issuer, cumulative dividends at the annual rate of 5% of the Stated Value per share of Series A Preferred Stock. Such dividends shall accrue on each such share commencing on the date of issue, and shall accrue from day to day, whether or not earned or declared. Subject to the terms of the Series A COD, at any time the Issuer shall be entitled to redeem any or all of the outstanding shares of Series A Preferred Stock at a per share price equal to 125% of the Stated Value plus accumulated dividends, payable in cash.